IFNA1 and systemic lupus erythematosus: The increased activity of an unestablished and unidentified substance in the serum of a lupus patient which leads to increased stimulatory function of T cells in an allogeneic reaction system with a mixed composition of lymphocytes is inhibited by anti-IFN-α antibodies.